ON THE HISTOPATHOLOGICAL PATTERNS OF THE PLACENTA IN WOMEN WITH COVID-19 DURING PREGNANCY: CROSS-SECTIONAL STUDY
DOI:
https://doi.org/10.32782/2226-2008-2024-2-4Keywords:
COVID-19, pregnancy, histopathology of the placenta.Abstract
Background. The COVID-19 pandemic has led to an active surge of studies devoted to the course of pregnancy under conditions of this infection, perinatal outcomes and long-term results, morphohistological features of the placental complex. In case of COVID-19, the placenta can be both a target organ for damage and a barrier between the mother and the fetus. Materials and methods. 58 women with a confirmed (real-time PCR) moderately severу COVID-19 during pregnancy (the main group) and 40 healthy pregnant women (the control group) took part in a case-control study. The study was conducted from November 1, 2021 to December 31, 2022 from on the basis of the Communal Non-Profit Enterprise “Maternity Hospital No. 2” (Odesa). Socio-demographic data and perinatal outcomes have been analyzed. The placentas were subjected to histological examination and described in accordance with the recommendations of the Amsterdam Consensus of the Placental Working Group. Statistical analysis was performed on the platform https://www.socscistatistics.com/tests/. Results. The study and control groups were comparable in terms of demographic and anthropometric data. The incidence of COVID-19 was higher in the 2nd and 3rd trimesters of pregnancy (F=148.38358, p<0.00001). Significantly more often in “post-COVID” placentas, hemodynamic disorders were detected in the form of plethora and hemorrhages (53.45% vs 15%, OR= 6.506, 95% CI 2.370 17.858), maternal vascular malperfusion – villi infarctions (53.45% vs 12.5%, OR=8.037, 95% CI 2.758 23.423), agglutination of villi with an increase in the number of syncytial nodules (79.31% vs 15%, OR=21.722, 95% CI 7.409 63.684), vascular malperfusion of the fetus – hypovascularisation of the villi (only in 8.62% in the main group), and lymphoid infiltration of fetal membranes (17.24% vs 12.5%, OR=1.458, 95% CI 0.458 81.777). Conclusion. The histopathological patterns found in post-COVID placentas indicate a significant impact of coronavirus infection on placental structure, but these changes are not specific and further research is needed to provide an evidence base.
References
Burton GJ, Fowden AL. The placenta: a multifaceted, transient organ. Philos Trans R Soc Lond B Biol Sci. 2015; 370(1663):
doi: 10.1098/rstb.2014.0066. https://doi/full/10.1098/rstb.2014.0066.
Lad SK, Jashnani KD, Pophalkar M, et al. Study of placental histopathology in COVID-19 mothers at a dedicated COVID-19
hospital in India. J Postgrad Med. 2024; 70(1): 15–22. doi: 10.4103/jpgm.jpgm_60_23. https://journals.lww.com/jopm/
abstract/2024/70010/study_of_placental_histopathology_in_covid_19.6.aspx.
Ding J, Maxwell A, Adzibolosu N, et al. Mechanisms of immune regulation by the placenta: Role of type I interferon
and interferon-stimulated genes signaling during pregnancy. Immunol Rev. 2022;308(1):9-24. doi: 10.1111/imr.13077.
https://onlinelibrary.wiley.com/doi/abs/10.1111/imr.13077.
Tanacan A, Yazihan N, Erol SA, et al. The impact of COVID-19 infection on the cytokine profile of pregnant women: A
prospective case-control study. Cytokine. 2021; 140: 155431. doi: 10.1016/j.cyto.2021.155431. https://www.sciencedirect.
com/science/article/pii/S1043466621000119.
Patiño Escarcina JE, da Silva AKCV, Medeiros MOdA, et al. Histological Alterations in Placentas of Pregnant Women
with SARS-CoV-2 Infection: A Single-Center Case Series. Pathogens. 2023; 12(10): 1197. https://doi.org/10.3390/
pathogens12101197.
Surekha MV, Suneetha N, Balakrishna N, et al. Impact of COVID-19 during pregnancy on placental pathology, maternal
and neonatal outcome – A cross-sectional study on anemic term pregnant women from a tertiary care hospital in southern
India. Front. Endocrinol. 2023; 14: 1092104. doi:10.3389/fendo.2023.1092104. https://doi.org/10.3389/fendo.2023.1092104
Khong TY, Mooney EE, Ariel I, et al. Sampling and Definitions of Placental Lesions: Amsterdam Placental Workshop
Group Consensus Statement. Arch Pathol Lab Med. 2016; 140(7): 698–713. doi: 10.5858/arpa.2015-0225-CC. https://doi.
org/10.5858/arpa.2015%2D0225%2DCC.
Baergen RN, Heller DS. Placental Pathology in Covid-19 Positive Mothers: Preliminary Findings. Pediatr Dev Pathol.
; 23(3): 177–180. doi: 10.1177/1093526620925569. https://doi.org/10.1177/1093526620925569.
Shanes ED, Mithal LB, Otero S, et al. Placental Pathology in COVID-19. Am J Clin Pathol. 2020; 154(1): 23–32. doi:
1093/ajcp/aqaa089. https://doi.org/10.1093/ajcp/aqaa089.
Milot C, Koch A, Averous G, et al. Development of placental lesions after recovery from COVID-19 during pregnancy:
case-control study. BJOG. 2023; 130(8): 949–958. https://doi.org/10.1111/1471-0528.17458.
Hantoushzadeh S, Saeednejad R, Shariat M, et al. Pathological Examination of the Placenta in COVID-19-Positive Mothers:
A Short Communication. Iran J Pathol. 2023; 18(2): 217–220. doi: 10.30699/IJP.2023.551018.2860. https://www.ncbi.nlm.
nih.gov/pmc/articles/PMC10439745/.
Munro SK, Balakrishnan B, Lissaman AC, et al. Cytokines and pregnancy: Potential regulation by histone deacetylases. Mol.
Reprod. Dev. 2021; 88(5): 321–337. https://doi.org/10.1002/mrd.23430.
Chen L, Li Q, Zheng D, et al. Clinical Characteristics of Pregnant Women with COVID-19 in Wuhan, China. N Engl J Med.
; 382(25): e100. doi: 10.1056/NEJMc2009226. https://doi/full/10.1056/nejmc2009226.
Wong YP, Tan GC, Omar SZ, et al. SARS-CoV-2 Infection in Pregnancy: Placental Histomorphological Patterns, Disease
Severity and Perinatal Outcomes. Int J Environ Res Public Health. 2022; 19(15): 9517. doi: 10.3390/ijerph19159517.
https://www.mdpi.com/1660-4601/19/15/9517.
Magawa S, Nii M, Enomoto N, et al. COVID-19 during pregnancy could potentially affect placental function. The Journal
of Maternal-Fetal & Neonatal Medicine. 2023; 36(2): 2265021 doi: 10.1080/14767058.2023.2265021. https://doi/full/10.1
/14767058.2023.2265021.
Bertero L, Borella F, Botta G. et al. Placenta histopathology in SARS-CoV-2 infection: analysis of a consecutive series and
comparison with control cohorts. Virchows Arch. 2021; 479: 715–728. https://doi.org/10.1007/s00428-021-03097-3.